Otezla 30 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FA1GX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $67,793
Award facts
- Contract value 100% obligated
- $67,793.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 20, 2026, the Defense Logistics Agency awarded a delivery order valued at $67,793.04 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units). This firm fixed-price delivery order, which is not associated with any set-aside program, represents a competitive award to the prime contractor. The contract is scheduled for ultimate completion on January 21, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, a $999,999,999 prime contract vehicle designated SPE2DX and running through December 2026. This comprehensive global pharmaceutical support contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including brand-name and generic medications, vaccines, and specialized medical commodities. The Defense Logistics Agency Medical Supply Chain utilizes this prime vendor arrangement to ensure efficient delivery of critical pharmaceutical products to military treatment facilities and the broader Defense Health Agency network.
Quick answers
Who was awarded contract SPE2DR26FA1GX?
SPE2DR26FA1GX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FA1GX worth?
The government has obligated $67,793 on SPE2DR26FA1GX.
Is contract SPE2DR26FA1GX an order under another contract?
Yes. SPE2DR26FA1GX is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA1GX competed?
The extent of competition for SPE2DR26FA1GX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award